Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
About this item
Full title
Author / Creator
Tawbi, Hussein A , Forsyth, Peter A , Algazi, Alain , Hamid, Omid , Hodi, F. Stephen , Moschos, Stergios J , Khushalani, Nikhil I , Lewis, Karl , Lao, Christopher D , Postow, Michael A , Atkins, Michael B , Ernstoff, Marc S , Reardon, David A , Puzanov, Igor , Kudchadkar, Ragini R , Thomas, Reena P , Tarhini, Ahmad , Pavlick, Anna C , Jiang, Joel , Avila, Alexandre , Demelo, Sheena and Margolin, Kim
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Brain metastases are a common cause of disabling neurologic complications and death in patients with metastatic melanoma. Previous studies of nivolumab combined with ipilimumab in metastatic melanoma have excluded patients with untreated brain metastases. We evaluated the efficacy and safety of nivolumab plus ipilimumab in patients with melanoma wh...
Alternative Titles
Full title
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Authors, Artists and Contributors
Author / Creator
Forsyth, Peter A
Algazi, Alain
Hamid, Omid
Hodi, F. Stephen
Moschos, Stergios J
Khushalani, Nikhil I
Lewis, Karl
Lao, Christopher D
Postow, Michael A
Atkins, Michael B
Ernstoff, Marc S
Reardon, David A
Puzanov, Igor
Kudchadkar, Ragini R
Thomas, Reena P
Tarhini, Ahmad
Pavlick, Anna C
Jiang, Joel
Avila, Alexandre
Demelo, Sheena
Margolin, Kim
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8011001
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8011001
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1805453
